In healthy cells and precancerous cells, TGFβ signaling plays critical roles in maintaining cellular hemostasis and reversing malignant transition, while in cancer cells, this pathway sustains oncogenic transformation, such as epithelial-to-mesenchymal transition (EMT), migration, immune surveillance evasion and chemoresistance5,6. This evidence concerns the gene TGFB1 and cancer.